At Guatemala's national paediatric oncology unit, 787 children with ALL treated in 2007 to 2014 had five-year overall survival of 64.1%; the authors call outcomes suboptimal because of late diagnosis, early deaths and a high relapse rate.
Published as "The treatment of childhood acute lymphoblastic leukemia in Guatemala: Biologic features, treatment hurdles, and results". Children aged 1 to 17 were treated at UNOP on a modified ALL IC-BFM 2002 protocol with risk groups set by age, white cell count, immunophenotype, genetics where available and early response.
An organised centre in a lower-middle-income country can overcome malnutrition and reduce abandonment, but earlier diagnosis and better management of complications are still needed.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/